Artificial Intelligence in ALK -Rearranged NSCLC: Forecasting Response and Resistance.
Simple Summary: ALK-positive non-small-cell lung cancer is a distinct molecular subtype for which targeted therapies have significantly enhanced patient outcomes. However, prediction of treatment response and understanding of resistance mechanisms remain clinically challenging. Artificial intelligen...
| Publicado en: | Cancers Vol. 18; no. 6; pp. 973 - 989 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
MDPI
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |